Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis

Human papillomavirus (HPV) induced cervical cancer is the second most common cause of death, after breast cancer, in females. Three prophylactic vaccines by Merck Sharp & Dohme (MSD) and GlaxoSmithKline (GSK) have been confirmed to prevent high-risk HPV strains but these vaccines have been shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabbar, Basit, Rafique, Shazia, Salo-Ahen, Outi M. H., Ali, Amjad, Munir, Mobeen, Idrees, Muhammad, Mirza, Muhammad Usman, Vanmeert, Michiel, Shah, Syed Zawar, Jabbar, Iqra, Rana, Muhammad Adeel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305797/
https://www.ncbi.nlm.nih.gov/pubmed/30619353
http://dx.doi.org/10.3389/fimmu.2018.03000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305797/
https://www.ncbi.nlm.nih.gov/pubmed/30619353
http://dx.doi.org/10.3389/fimmu.2018.03000

Ejemplares similares